CCPA (2-Chloro-N6-cyclopentyladenosine) a highly selective A1 adenosine receptors agonist with a Ki of 0.4 nM. CCPA inhibits adenylate cyclase with an IC50 of 33 nM. CCPA exhibits anti-seizure and cardiacprotective activity. CCPA can be used for the research of seizure and myocardial infarction[1][2][3].
Molecular Weight:
369.80
Purity:
99.77
CAS Number:
[37739-05-2]
Formula:
C15H20ClN5O4
Target:
Adenosine Receptor,Adenylate Cyclase
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted